🇺🇸 FDA
Patent

US 11208413

Pyrimidopyrimidinones useful as wee-1 kinase inhibitors

granted A61KA61K31/519A61P

Quick answer

US patent 11208413 (Pyrimidopyrimidinones useful as wee-1 kinase inhibitors) held by ALMAG DISCOVERY LIMITED expires Mon Dec 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ALMAG DISCOVERY LIMITED
Grant date
Tue Dec 28 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K31/519, A61P, A61P35/00